1-16 of 16
Li Wang
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

A Novel Lipid Nanoparticle NBF-006 Encapsulating Glutathione S-Transferase P siRNA for the Treatment of KRAS-Driven Non–small Cell Lung Cancer

Available to Purchase
Cima Cina, Bharat Majeti, Zhihong O’Brien, Li Wang, Jean Pierre Clamme, Roger Adami, Kwok Yin Tsang, Jens Harborth, Wenbin Ying, Sonya Zabludoff
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2025) 24 (1): 7–17.
https://doi.org/10.1158/1535-7163.MCT-23-0915
Published: 02 January 2025
View articletitled, A Novel Lipid Nanoparticle NBF-006 Encapsulating Glutathione S-Transferase P siRNA for the Treatment of KRAS-Driven Non–small Cell Lung Cancer
Open the PDF for A Novel Lipid Nanoparticle NBF-006 Encapsulating Glutathione S-Transferase P siRNA for the Treatment of KRAS-Driven Non–small Cell Lung Cancer in another window
Includes: Supplementary data
Journal Articles

The Methyltransferases METTL7A and METTL7B Confer Resistance to Thiol-Based Histone Deacetylase Inhibitors

Free
Robert W. Robey, Christina M. Fitzsimmons, Wilfried M. Guiblet, William J.E. Frye, José M. González Dalmasy, Li Wang, Drake A. Russell, Lyn M. Huff, Andrew J. Perciaccante, Fatima Ali-Rahmani, Crystal C. Lipsey, Heidi M. Wade, Allison V. Mitchell, Siddhardha S. Maligireddy, David Terrero, Donna Butcher, Elijah F. Edmondson, Lisa M. Jenkins, Tatiana Nikitina, Victor B. Zhurkin, Amit K. Tiwari, Anthony D. Piscopio, Rheem A. Totah, Susan E. Bates, H. Efsun Arda, Michael M. Gottesman, Pedro J. Batista
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2024) 23 (4): 464–477.
https://doi.org/10.1158/1535-7163.MCT-23-0144
Published: 02 April 2024
View articletitled, The Methyltransferases METTL7A and METTL7B Confer Resistance to Thiol-Based Histone Deacetylase Inhibitors
Open the PDF for The Methyltransferases METTL7A and METTL7B Confer Resistance to Thiol-Based Histone Deacetylase Inhibitors in another window
Includes: Supplementary data
Journal Articles

Abstract B060: Dual blockade of BRD4 and the ATR/WEE1 pathway exploits ARID1A loss in clear cell ovarian cancer

Free
Yasuto Kinose, Haineng Xu, Sushil Kumar, Hyoung Kim, Sergey Medvedev, Xiaolei Wang, Erin George, Xiaoyin Shan, Sarah Gitto, Kurt D'Andrea, Bradley Wubbenhorst, Margaret Whicker, Dorothy Hallberg, Lauren Schwartz, Katherine L Nathanson, Gordon Mills, Victor E Velculescu, Tian-Li Wang, Eric Brown, Ronny Drapkin, Fiona Simpkins
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2023) 22 (12_Supplement): B060.
https://doi.org/10.1158/1535-7163.TARG-23-B060
Published: 01 December 2023
View articletitled, Abstract B060: Dual blockade of BRD4 and the ATR/WEE1 pathway exploits ARID1A loss in clear cell ovarian cancer
Journal Articles

Tumor-Infiltrating Myeloid Cells Confer De Novo Resistance to PD-L1 Blockade through EMT–Stromal and Tgfβ-Dependent Mechanisms

Available to Purchase
Haocheng Yu, John P. Sfakianos, Li Wang, Yang Hu, Jorge Daza, Matthew D. Galsky, Harkirat S. Sandhu, Olivier Elemento, Bishoy M. Faltas, Adam M. Farkas, Nina Bhardwaj, Jun Zhu, David J. Mulholland
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2022) 21 (11): 1729–1741.
https://doi.org/10.1158/1535-7163.MCT-22-0130
Published: 03 November 2022
View articletitled, Tumor-Infiltrating Myeloid Cells Confer De Novo Resistance to PD-L1 Blockade through EMT–Stromal and Tgfβ-Dependent Mechanisms
Open the PDF for Tumor-Infiltrating Myeloid Cells Confer De Novo Resistance to PD-L1 Blockade through EMT–Stromal and Tgfβ-Dependent Mechanisms in another window
Includes: Supplementary data
Journal Articles

A Preclinical Study to Repurpose Spironolactone for Enhancing Chemotherapy Response in Bladder Cancer

Available to Purchase
Dongbo Xu, Qiang Cao, Li Wang, Jianmin Wang, Bo Xu, Kristopher Attwood, Lei Wei, Yue Wu, Gary J. Smith, Eriko Katsuta, Kazuaki Takabe, Gurkamal Chatta, Khurshid A. Guru, David W. Goodrich, Qiang J. Li
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2022) 21 (5): 786–798.
https://doi.org/10.1158/1535-7163.MCT-21-0613
Published: 04 May 2022
View articletitled, A Preclinical Study to Repurpose Spironolactone for Enhancing Chemotherapy Response in Bladder Cancer
Open the PDF for A Preclinical Study to Repurpose Spironolactone for Enhancing Chemotherapy Response in Bladder Cancer in another window
Includes: Supplementary data
Journal Articles

Combined Inhibition of Rad51 and Wee1 Enhances Cell Killing in HNSCC Through Induction of Apoptosis Associated With Excessive DNA Damage and Replication Stress

Free
Antje Lindemann, Ameeta A. Patel, Lin Tang, Noriaki Tanaka, Frederico O. Gleber-Netto, Mason D. Bartels, Li Wang, Daniel J. McGrail, Shiaw-Yih Lin, Steven J. Frank, Mitchell J. Frederick, Jeffrey N. Myers, Abdullah A. Osman
Journal: Molecular Cancer Therapeutics
Series: Author Choice
Mol Cancer Ther (2021) 20 (7): 1257–1269.
https://doi.org/10.1158/1535-7163.MCT-20-0252
Published: 01 July 2021
View articletitled, Combined Inhibition of Rad51 and Wee1 Enhances Cell Killing in HNSCC Through Induction of Apoptosis Associated With Excessive DNA Damage and Replication Stress
Open the PDF for Combined Inhibition of Rad51 and Wee1 Enhances Cell Killing in HNSCC Through Induction of Apoptosis Associated With Excessive DNA Damage and Replication Stress in another window
Includes: Supplementary data
Journal Articles

A Novel Bispecific Antibody with PD-L1–assisted OX40 Activation for Cancer Treatment

Available to Purchase
Zhihui Kuang, Pu Pu, Min Wu, Zhihai Wu, Li Wang, Yiming Li, Shaofei Zhang, Hua Jing, Weiwei Wu, Bingliang Chen, Junjian Liu
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2020) 19 (12): 2564–2574.
https://doi.org/10.1158/1535-7163.MCT-20-0226
Published: 02 December 2020
View articletitled, A Novel Bispecific Antibody with PD-L1–assisted OX40 Activation for Cancer Treatment
Open the PDF for A Novel Bispecific Antibody with PD-L1–assisted OX40 Activation for Cancer Treatment in another window
Includes: Supplementary data
Journal Articles

Abstract C022: Large scale phenotypic screening using PRISM, integrated with functional genomic screening and transcriptional profiling accelerates target identification of cytotoxic small molecules

Free
Kevin Larpenteur, Lucian de Waal, Li Wang, Mustafa Kocak, Jordan Bryan, Samantha Bender, Sulyman Barkho, Matt Kukurugya, Amy Goodale, Brenton Paolella, Min Cho, James McFarland, Michael Rothberg, Cong Zhu, Colin Trepiccio, Aviad Tsherniak, David Root, Bryson Bennett, Federica Piccioni, Josh Bittker, James Rong, Christopher Mader, David Stokoe, Ari Firestone, Todd R Golub, Jennifer Roth
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2019) 18 (12_Supplement): C022.
https://doi.org/10.1158/1535-7163.TARG-19-C022
Published: 01 December 2019
View articletitled, Abstract C022: Large scale phenotypic screening using PRISM, integrated with functional genomic screening and transcriptional profiling accelerates target identification of cytotoxic small molecules
Journal Articles

Abstract B121: An oncogene-linked prodrug strategy in lung cancer

Free
Aaron Boudreau, Jennifer Roth, James Rong, Niclas Olsson, Chris Mader, Jordan Byran, Jordan Rossen, Li Wang, Kevin Larpenteur, Amy Goodale, Colin Trepicchio, Samantha Bender, Aviad Tsherniak, Aravind Subramanian, Mustafa Kocak, Federica Piccioni, Josh Bittker, Cong Zhu, Frank Li, Nick Eriksson, Daphne Koller, Fiona McAllister, Todd Golub, Jeff Settleman, Ari Firestone, David Stokoe
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2019) 18 (12_Supplement): B121.
https://doi.org/10.1158/1535-7163.TARG-19-B121
Published: 01 December 2019
View articletitled, Abstract B121: An oncogene-linked prodrug strategy in lung cancer
Journal Articles

Auranofin Enhances Ibrutinib's Anticancer Activity in EGFR-Mutant Lung Adenocarcinoma

Available to Purchase
Jing Hu, Huijuan Zhang, Mengru Cao, Li Wang, Shuhong Wu, Bingliang Fang
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2018) 17 (10): 2156–2163.
https://doi.org/10.1158/1535-7163.MCT-17-1173
Published: 01 October 2018
View articletitled, Auranofin Enhances Ibrutinib's Anticancer Activity in EGFR-Mutant Lung Adenocarcinoma
Open the PDF for Auranofin Enhances Ibrutinib's Anticancer Activity in EGFR-Mutant Lung Adenocarcinoma in another window
Includes: Supplementary data
Journal Articles

A Novel Small Molecule Activator of Nuclear Receptor SHP Inhibits HCC Cell Migration via Suppressing Ccl2

Available to Purchase
Zhihong Yang, Angela N. Koehler, Li Wang
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2016) 15 (10): 2294–2301.
https://doi.org/10.1158/1535-7163.MCT-16-0153
Published: 02 October 2016
View articletitled, A Novel Small Molecule Activator of Nuclear Receptor SHP Inhibits HCC Cell Migration via Suppressing Ccl2
Open the PDF for A Novel Small Molecule Activator of Nuclear Receptor SHP Inhibits HCC Cell Migration via Suppressing Ccl2 in another window
Includes: Supplementary data
Journal Articles

IGFBP2/FAK Pathway Is Causally Associated with Dasatinib Resistance in Non–Small Cell Lung Cancer Cells

Available to Purchase
Haibo Lu, Li Wang, Wen Gao, Jieru Meng, Bingbing Dai, Shuhong Wu, John Minna, Jack A. Roth, Wayne L. Hofstetter, Stephen G. Swisher, Bingliang Fang
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2013) 12 (12): 2864–2873.
https://doi.org/10.1158/1535-7163.MCT-13-0233
Published: 05 December 2013
View articletitled, IGFBP2/FAK Pathway Is Causally Associated with Dasatinib Resistance in Non–Small Cell Lung Cancer Cells
Open the PDF for IGFBP2/FAK Pathway Is Causally Associated with Dasatinib Resistance in Non–Small Cell Lung Cancer Cells in another window
Includes: Supplementary data
Journal Articles

Abstract C234: A novel microtubule inhibitor BPR0L075 overcomes paclitaxel resistance in ovarian cancer cell lines

Free
Xinli Liu, Xiaolei Wang, Sean Tedjarati, Tian‐Li Wang, Hsing‐Pang Hsieh
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2009) 8 (12_Supplement): C234.
https://doi.org/10.1158/1535-7163.TARG-09-C234
Published: 10 December 2009
View articletitled, Abstract C234: A novel microtubule inhibitor BPR0L075 overcomes paclitaxel resistance in ovarian cancer cell lines
Journal Articles

Interruption of RNA processing machinery by a small compound, 1-[(4-chlorophenyl)methyl]-1H-indole-3-carboxaldehyde (oncrasin-1)

Available to Purchase
Wei Guo, Shuhong Wu, Li Wang, Rui-yu Wang, Xiaoli Wei, Jinsong Liu, Bingliang Fang
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2009) 8 (2): 441–448.
https://doi.org/10.1158/1535-7163.MCT-08-0839
Published: 11 February 2009
View articletitled, Interruption of RNA processing machinery by a small compound, 1-[(4-chlorophenyl)methyl]-1H-indole-3-carboxaldehyde (oncrasin-1)
Open the PDF for Interruption of RNA processing machinery by a small compound, 1-[(4-chlorophenyl)methyl]-1H-indole-3-carboxaldehyde (oncrasin-1) in another window
Includes: Supplementary data
Journal Articles

Expression of the chromatin remodeling factor Rsf-1 in breast carcinoma effusions predicts poor survival

Free
Ben Davidson, Tian-Li Wang, Ie-Ming Shih, Aasmund Berner
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2007) 6 (11_Supplement): B129.
Published: 01 November 2007
View articletitled, Expression of the chromatin remodeling factor Rsf-1 in breast carcinoma effusions predicts poor survival
Journal Articles

The role of NAC-1 in the development of taxol-resistant ovarian cancers

Free
Natini Jinawath, Kentaro Nakayama, Chanont Vasoontara, Bill Ricketts, Eugene Mechetner, Tian-Li Wang, Ie-Ming Shih
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2007) 6 (11_Supplement): A201.
Published: 01 November 2007
View articletitled, The role of NAC-1 in the development of taxol-resistant ovarian cancers